MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

ADIAL PHARMACEUTICALS, INC. (ADIL)

ADIAL PHARMACEUTICALS, INC. (ADIL)

|||

Balance Sheets Overview

Current Ratio
563.27%
Quick Ratio
563.27%
Debt to Asset Ratio
99.46%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Equity method investment
    • Prepaid expenses and other curre...
    • Intangible assets, net
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Series a convertible preferred s...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
28,712,000
4,584,100
4,606,289
5,914,980
Prepaid expenses and other current assets
133,000
218,848
407,543
163,647
Total current assets
28,845,000
4,802,948
5,013,832
6,078,627
Intangible assets, net
3,000
2,643
2,925
3,066
Equity method investment
241,000
421,730
643,090
720,010
Total assets
29,089,000
5,227,321
5,659,847
6,801,703
Accounts payable, related party-Related Party
-
-
-
0
Accounts payable
2,624,000
573,567
556,284
671,118
Accrued expenses
2,497,000
936,504
598,472
539,909
Total current liabilities
5,121,000
1,510,071
1,154,756
1,211,027
Milestone warrant rights liability
23,812,000
-
-
-
Total liabilities
28,933,000
1,510,071
1,154,756
1,211,027
Series a convertible preferred stock, 0.001 par value 13,000 and 0 shares designated as of june 30, 2026 and december 31, 2025, respectively 12,930.617 and 0 shares issued and outstanding as of june 30 2026 and december 31, 2025, respectively
38,533,000
-
-
-
Common stock, 100,000,000 shares authorized with a par value of 0.001 per share, 2,625,890 and 1,111,010 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
3,000
1,509
23,836
21,535
Additional paid in capital
105,604,000
95,710,627
92,457,586
91,751,821
Accumulated deficit
-143,984,000
-91,994,886
-87,976,331
-86,182,680
Total stockholders (deficit) equity
-38,377,000
3,717,250
4,505,091
5,590,676
Total liabilities, temporary equity and stockholders (deficit) equity
29,089,000
5,227,321
5,659,847
6,801,703
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$28,712,000 (385.41%↑ Y/Y)Prepaid expenses andother current assets$133,000 (-18.73%↓ Y/Y)Total current assets$28,845,000 (374.53%↑ Y/Y)Equity methodinvestment$241,000 (-66.53%↓ Y/Y)Intangible assets, net$3,000 (-2.15%↓ Y/Y)Total assets$29,089,000 (327.67%↑ Y/Y)Accumulated deficit-$143,984,000 (-67.07%↓ Y/Y)Total liabilities,temporary equity and...$29,089,000 (327.67%↑ Y/Y)Total stockholders(deficit) equity-$38,377,000 (-786.45%↓ Y/Y)Additional paid in capital$105,604,000 (15.10%↑ Y/Y)Common stock,100,000,000 shares...$3,000 (-86.07%↓ Y/Y)Series a convertiblepreferred stock, 0.001 par...$38,533,000 Total liabilities$28,933,000 (2289.13%↑ Y/Y)Milestone warrant rightsliability$23,812,000 Total currentliabilities$5,121,000 (322.86%↑ Y/Y)Accounts payable$2,624,000 (290.99%↑ Y/Y)Accrued expenses$2,497,000 (362.49%↑ Y/Y)